<?xml version="1.0" encoding="UTF-8"?>
<fig id="f1-dddt-3-289" position="float">
 <label>Figure 1</label>
 <caption>
  <p>Efficacy of HBPG against HSV-2 encephalitis in mice after various delays in starting dosing post-infection. HBPG was given twice daily for five days.</p>
  <p>
   <bold>Notes:</bold> For reduction of mortality, 
   <italic>P</italic> &lt; 0.05 at one and two days postinfection (Fisher’s exact test). For MDD, 
   <italic>P</italic> &lt; 0.05 at one and two days postinfection (Mann–Whitney 
   <italic>U</italic> test).
  </p>
  <p>
   <bold>Abbreviations:</bold> HBPG, 2-phenylamino-6-oxo-9-(4-hydroxybutyl)purine; HSV, herpes simplex virus; MDD, mean day of death.
  </p>
 </caption>
 <graphic xlink:href="dddt-3-289f1" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
